Seminars in Liver Disease

LinksSchließen

Referenz

Lip GYH, Pan X, Kamble S. , et al.
Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real-world” observational study in the United States.

Int J Clin Pract 2016;
70 (09) 752-763

Bibliographische Angaben herunterladen

Aufrufen in: